1. Human interleukin-2 molecular biology, physiology and clinical possibilities;Mertelsmann;Immunobiol,1986
2. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor;Lotze;Cancer Res,1981
3. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types;Papa;Cancer Res,1986
4. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma;Lafreniere;J Immunol,1985
5. Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin-2;Eberlein;J Exp Med,1982